Client Result
Orrick represents AEONMED in successful action against ministerial prohibition to acquire Heyer
November.16.2023
November.16.2023
November.01.2023
October.04.2023
September.15.2023
August.28.2023
Ferring Pharmaceuticals and Royalty Pharma have entered into a royalty agreement for sales of Ferring’s new gene therapy for bladder cancer.
July.20.2023
July.10.2023
June.07.2023
Orrick ranks among Seramount's top 5 firms – and it’s our 15th year on the list.
May.17.2023
Resurrect Bio, a biotech startup using gene editing to protect crops from disease, has completed a seed investment round to fuel its growth.
March.13.2023
March.06.2023
March.02.2023
The proceeds from the financing will be used to advance CARGO’s autologous CD22 CAR T-cell therapy candidate, CRG-022.